{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:03:02Z","timestamp":1790996582400,"version":"4.1.0"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["2014 RRIA\/10189"],"award-info":[{"award-number":["2014 RRIA\/10189"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00679 , PI16\/00005, JR15\/00008"],"award-info":[{"award-number":["PI14\/00679 , PI16\/00005, JR15\/00008"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01294","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:50:14Z","timestamp":1572396614000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Ane","family":"Murueta-Goyena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Andikoetxea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"G\u00f3mez-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"Gabilondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1523\/jneurosci.5046-10.2011","article-title":"Synapse loss in olfactory local interneurons modifies perception","volume":"31","author":"Acebes","year":"2011","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/wnl.0000000000006157","article-title":"Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease","volume":"91","author":"Ahn","year":"2018","journal-title":"Neurol."},{"key":"B6","first-page":"3659","article-title":"Olfactory disfunction and its relation olfactory bulb volume in Parkinson\u2019s disease","volume":"18","author":"Altinayar","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5664\/jcsm.27492","article-title":"Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam","volume":"5","author":"Anderson","year":"2009","journal-title":"J. Clin. Sleep. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1148\/radiol.2017161732","article-title":"Visual system involvement in patients with newly diagnosed parkinson disease","volume":"285","author":"Arrigo","year":"2017","journal-title":"Radiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2014.12.001","article-title":"GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation","volume":"93","author":"Auteri","year":"2015","journal-title":"Pharmacol. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4996","DOI":"10.2174\/1381612821666150914121518","article-title":"The GABAergic system and the gastrointestinal physiopathology","volume":"21","author":"Auteri","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/zsx071","article-title":"Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder","volume":"40","author":"Barber","year":"2017","journal-title":"Sleep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2125.1993.tb04206.x","article-title":"GABA-ergic control of visual perception in healthy volunteers: effects of midazolam, a benzodiazepine, on spatio-temporal contrast sensitivity","volume":"36","author":"Blin","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/brain\/awq079","article-title":"Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson\u2019s disease","volume":"133","author":"Bohnen","year":"2010","journal-title":"Brain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1523\/jneurosci.2617-13.2014","article-title":"Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat","volume":"34","author":"Boucetta","year":"2014","journal-title":"J Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/mds.25087","article-title":"Decreased olfactory bulb volume in idiopathic Parkinson\u2019s disease detected by 3.0-tesla magnetic resonance imaging","volume":"27","author":"Brodoehl","year":"2012","journal-title":"Mov. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1523\/jneurosci.0347-11.2011","article-title":"Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice","volume":"31","author":"Brooks","year":"2011","journal-title":"J Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2015.01.028","article-title":"Glutamate and GABA concentration changes in the globus pallidus internus of Parkinson\u2019s patients during performance of implicit and declarative memory tasks: a report of two subjects","volume":"589","author":"Buchanan","year":"2015","journal-title":"Neurosci. Lett."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201964","article-title":"Cognition among individuals along a spectrum of increased risk for Parkinson\u2019s disease","volume":"13","author":"Chahine","year":"2018","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/1756285613495723","article-title":"Anxiety in Parkinson\u2019s disease: identification and management","volume":"7","author":"Chen","year":"2014","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng","year":"2010","journal-title":"Ann. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neulet.2016.07.053","article-title":"GABA predicts visual intelligence","volume":"632","author":"Cook","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat Rev. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","article-title":"Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease","volume":"3","author":"Dudley","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/wnl.32.3.312","article-title":"Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality","volume":"32","author":"Dupont","year":"1982","journal-title":"Neurol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030918","article-title":"Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS","volume":"7","author":"Emir","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/sleep\/34.5.619","article-title":"Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder","volume":"34","author":"Fantini","year":"2011","journal-title":"Sleep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.brainresbull.2006.07.008","article-title":"Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder","volume":"70","author":"Fantini","year":"2006","journal-title":"Brain. Res. Bull."},{"key":"B29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.biopsych.2017.05.024","article-title":"Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: cortical microcircuit and therapeutic perspectives","volume":"82","author":"Fee","year":"2017","journal-title":"Biol. Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mds.26989","article-title":"Validation of the MDS research criteria for prodromal Parkinson\u2019s disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort","volume":"32","author":"Fereshtehnejad","year":"2017","journal-title":"Mov. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000101726.69701.fa","article-title":"Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist","volume":"62","author":"Ferini-Strambi","year":"2004","journal-title":"Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s00415-014-7317-8","article-title":"Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study","volume":"261","author":"Ferini-Strambi","year":"2014","journal-title":"J. Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.parkreldis.2015.09.002","article-title":"REM sleep Behaviour Disorder","volume":"22","author":"Ferini-Strambi","year":"2016","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1212\/wnl.0000000000006007","article-title":"Reduced occipital GABA in Parkinson disease with visual hallucinations","volume":"91","author":"Firbank","year":"2018","journal-title":"Neurol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/mp.2016.188","article-title":"Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state","volume":"22","author":"Fuchs","year":"2016","journal-title":"Mol. Psychiatry."},{"key":"B36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ana.21680","article-title":"Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson\u2019s disease","volume":"66","author":"Gagnon","year":"2009","journal-title":"Ann. Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/smrv.2002.0229","article-title":"Parkinson\u2019s disease and sleep","volume":"7","author":"Garcia-Borreguero","year":"2003","journal-title":"Sleep. Med. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1038\/s41598-017-10659-6","article-title":"Metal concentrations and distributions in the human olfactory bulb in Parkinson\u2019s disease","volume":"7","author":"Gardner","year":"2017","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/sleep\/zsw014","article-title":"Detecting the cognitive prodrome of dementia with lewy bodies: a prospective study of rem sleep behavior disorder","volume":"40","author":"Genier Marchand","year":"2017","journal-title":"Sleep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"16084","DOI":"10.1038\/srep16084","article-title":"Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson\u2019s disease","volume":"5","author":"Hajj","year":"2015","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2014.09.037","article-title":"GABA-mediated changes in inter-hemispheric beta frequency activity in early-stage Parkinson\u2019s disease","volume":"281","author":"Hall","year":"2014","journal-title":"Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.clinph.2009.11.084","article-title":"GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke\u2013a case report","volume":"121","author":"Hall","year":"2010","journal-title":"Clin. Neurophysiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson\u2019s disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain."},{"key":"B44","article-title":"The effect of retinal GABA Depletion by Allylglycine on mouse retinal ganglion cell responses to light","author":"Hilgen","year":"2015"},{"key":"B45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"Hogl","year":"2018","journal-title":"Nat Rev. Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ. Parkinsons Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-018-2852-8","article-title":"The REM sleep circuit and how its impairment leads to REM sleep behavior disorder","volume":"373","author":"Iranzo","year":"2018","journal-title":"Cell. Tissue. Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","article-title":"Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study","volume":"5","author":"Iranzo","year":"2006","journal-title":"Lancet. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1212\/wnl.0000000000004121","article-title":"Characterization of patients with longstanding idiopathic REM sleep behavior disorder","volume":"89","author":"Iranzo","year":"2017","journal-title":"Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13041-019-0426-7","article-title":"Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations","volume":"12","author":"Iwasawa","year":"2019","journal-title":"Mol. Brain."},{"key":"B51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","article-title":"Occurrence of depression and anxiety prior to Parkinson\u2019s disease","volume":"16","author":"Jacob","year":"2010","journal-title":"Parkinsonism. Relat. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","article-title":"GABA is an effective immunomodulatory molecule","volume":"45","author":"Jin","year":"2013","journal-title":"Amino. Acids."},{"key":"B53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/da.20262","article-title":"Role of GABA in anxiety and depression","volume":"24","author":"Kalueff","year":"2007","journal-title":"Depress. Anxiety"},{"key":"B54","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1523\/jneurosci.5753-10.2011","article-title":"GABAA inhibition controls response gain in visual cortex","volume":"31","author":"Katzner","year":"2011","journal-title":"J Neurosci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/s1474-4422(10)70212-x","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet. Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40478-016-0334-3","article-title":"Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations","volume":"4","author":"Khundakar","year":"2016","journal-title":"Acta. Neuropathol. Commun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1017\/s0317167100011501","article-title":"Stereopsis in drug naive Parkinson\u2019s disease patients","volume":"38","author":"Kim","year":"2011","journal-title":"Can J. Neurol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/ana.410200106","article-title":"Elevated gamma-aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson\u2019s disease: correlation with striatal dopamine loss","volume":"20","author":"Kish","year":"1986","journal-title":"Ann. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/s1474-4422(18)30162-5","article-title":"In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study","volume":"17","author":"Knudsen","year":"2018","journal-title":"Lancet. Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainres.2013.07.025","article-title":"Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson\u2019s disease","volume":"1531","author":"Lanoue","year":"2013","journal-title":"Brain. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.expneurol.2010.09.001","article-title":"Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson\u2019s disease","volume":"226","author":"Lanoue","year":"2010","journal-title":"Exp. Neurol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149286","article-title":"Changes in olfactory bulb volume in parkinson\u2019s disease: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS. One."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/s41467-018-03802-y","article-title":"GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease","volume":"9","author":"Lozovaya","year":"2018","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1212\/wnl.0000000000001265","article-title":"Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD","volume":"84","author":"Mahlknecht","year":"2015","journal-title":"Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00415-009-5328-7","article-title":"REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream","volume":"257","author":"Marques","year":"2010","journal-title":"J. Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/01.wnl.0000286943.79593.a6","article-title":"Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder","volume":"70","author":"Massicotte-Marquez","year":"2008","journal-title":"Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuropharm.2011.08.040","article-title":"The GABA system in anxiety and depression and its therapeutic potential","volume":"62","author":"Mohler","year":"2012","journal-title":"Neuropharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27728","article-title":"Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases","volume":"34","author":"Murueta-Goyena","year":"2019","journal-title":"Mov. Disord."},{"key":"B69","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02307822","article-title":"Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson\u2019s disease","volume":"10","author":"Nguyen-Legros","year":"1988","journal-title":"Surg. Radiol. Anat."},{"key":"B70","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fneur.2018.00806","article-title":"Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease","volume":"9","author":"O\u2019Gorman Tuura","year":"2018","journal-title":"Front. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pscychresns.2015.12.004","article-title":"Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: a case study","volume":"248","author":"Ota","year":"2016","journal-title":"Psychiatry. Res. Neuroimaging."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1212\/wnl.0000000000006134","article-title":"REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease","volume":"91","author":"Pagano","year":"2018","journal-title":"Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.870100309","article-title":"The anterior olfactory nucleus in Parkinson\u2019s disease","volume":"10","author":"Pearce","year":"1995","journal-title":"Mov. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11940-018-0539-9","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s Disease","volume":"20","author":"Pfeiffer","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1523\/jneurosci.0793-08.2008","article-title":"In vivo modulation of sensory input to the olfactory bulb by tonic and activity-dependent presynaptic inhibition of receptor neurons","volume":"28","author":"Pirez","year":"2008","journal-title":"J Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal parkinson\u2019s disease: the decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Mov. Disord."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/wnl.0000000000001364","article-title":"Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials","volume":"84","author":"Postuma","year":"2015","journal-title":"Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1093\/brain\/awp244","article-title":"Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson\u2019s disease","volume":"132","author":"Postuma","year":"2009","journal-title":"Brain."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/mds.25173","article-title":"The neurobiology and neural circuitry of cognitive changes in Parkinson\u2019s disease revealed by functional neuroimaging","volume":"27","author":"Ray","year":"2012","journal-title":"Mov. Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1016\/j.neuropsychologia.2007.06.002","article-title":"Recognition of category-related visual stimuli in Parkinson\u2019s disease: before and after pharmacological treatment","volume":"45","author":"Righi","year":"2007","journal-title":"Neuropsychologia."},{"key":"B83","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson\u2019s disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","article-title":"Neurotransmission systems in Parkinson\u2019s disease","volume":"28","author":"Sanjari Moghaddam","year":"2017","journal-title":"Rev. Neurosci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bpa.12511","article-title":"Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies","volume":"28","author":"Santpere","year":"2018","journal-title":"Brain. Pathol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.sleep.2011.09.012","article-title":"Impaired decision-making in idiopathic REM sleep behavior disorder","volume":"13","author":"Sasai","year":"2012","journal-title":"Sleep. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1093\/brain\/awt234","article-title":"Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson\u2019s disease","volume":"136","author":"Scherfler","year":"2013","journal-title":"Brain."},{"key":"B88","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/brain\/awh674","article-title":"Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson\u2019s disease","volume":"129","author":"Scherfler","year":"2006","journal-title":"Brain."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1152\/jn.91116.2008","article-title":"Two GABAergic intraglomerular circuits differentially regulate tonic and phasic presynaptic inhibition of olfactory nerve terminals","volume":"101","author":"Shao","year":"2009","journal-title":"J Neurophysiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/ene.13082","article-title":"Constipation: an emerging risk factor for Parkinson\u2019s disease","volume":"23","author":"Stirpe","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","article-title":"Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment","volume":"11","author":"Svenningsson","year":"2012","journal-title":"Lancet. Neurol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neulet.2016.03.050","article-title":"Associations of olfactory bulb and depth of olfactory sulcus with basal ganglia and hippocampus in patients with Parkinson\u2019s disease","volume":"620","author":"Tanik","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.5665\/sleep.3050","article-title":"Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study","volume":"36","author":"Terzaghi","year":"2013","journal-title":"Sleep."},{"key":"B94","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature11466","article-title":"Dopaminergic neurons inhibit striatal output through non-canonical release of GABA","volume":"490","author":"Tritsch","year":"2012","journal-title":"Nat."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01936","article-title":"Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis","volume":"3","author":"Tritsch","year":"2014","journal-title":"Elife."},{"key":"B96","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/mds.23933","article-title":"Patients with idiopathic rapid-eye-movement sleep behavior disorder show normal gastric motility assessed by the 13C-octanoate breath test","volume":"26","author":"Unger","year":"2011","journal-title":"Mov. Disord."},{"key":"B98","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cub.2013.03.067","article-title":"GABA shapes the dynamics of bistable perception","volume":"23","author":"van Loon","year":"2013","journal-title":"Curr. Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s004150170051","article-title":"Colour discrimination impairment is not a reliable early marker of Parkinson\u2019s disease","volume":"248","author":"Vesela","year":"2001","journal-title":"J. Neurol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson\u2019s disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain."},{"key":"B101","doi-asserted-by":"publisher","first-page":"12559","DOI":"10.1038\/s41598-017-12947-7","article-title":"Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson\u2019s disease","volume":"7","author":"Wen","year":"2017","journal-title":"Sci. Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/jnnp.2006.113860","article-title":"Functional imaging of the cerebral olfactory system in patients with Parkinson\u2019s disease","volume":"79","author":"Westermann","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B103","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5665\/sleep.3416","article-title":"Restless legs syndrome: an early clinical feature of Parkinson disease in men","volume":"37","author":"Wong","year":"2014","journal-title":"Sleep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1136\/jnnp-2015-311437","article-title":"Progression of cognitive impairments in idiopathic REM sleep behaviour disorder","volume":"87","author":"Youn","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/brain\/awx208","article-title":"A ventral glomerular deficit in Parkinson\u2019s disease revealed by whole olfactory bulb reconstruction","volume":"140","author":"Zapiec","year":"2017","journal-title":"Brain."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T04:17:28Z","timestamp":1611634648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":105,"alternative-id":["10.3389\/fphar.2019.01294"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01294","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"article-number":"1294"}}